FDA and the R&D Crisis: Time to Stop the Blame Game
By
Michael McCaughan / Email the Author / The RPM Report July 2011, Vol. 7, No. 7
Feature Articles / Word Count: 3675 / Article # 2011500088
Executive Summary
Everyone knows R&D productivity has dipped to levels that threaten the private drug development model, and almost everyone says regulatory hurdles are part of the problem. That isn’t how FDA sees it. One thing is clear: blaming FDA won’t help anyone, so it may be time to pay more attention to FDA’s ideas for solutions rather than continue to point fingers.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.